Browsing "1. College of Medicine (의과대학)" by Author : 3691

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 13 of 13

This table browses all dspace content
Issue DateTitleJournal Title
2021Abnormality in the NK-cell population is prolonged in severe COVID-19 patientsJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
2019Additional fibrate treatment in UDCA-refractory PBC patientsLIVER INTERNATIONAL
2016Clinical value of contrast-enhanced harmonic endoscopic ultrasonography in differential diagnosis of pancreas and gall bladder mass Thesis
2018Clinical Value of Contrast-Enhanced Harmonic Endoscopic Ultrasonography in the Differential Diagnosis of Pancreatic and Gallbladder Masses CLINICAL ENDOSCOPY
2013Glioma is formed by active Akt1 alone and promoted by active Rac1 in transgenic zebrafish NEURO-ONCOLOGY
2016Incidence and risk factors of delayed postpolypectomy bleeding in patients with chronic liver disease.SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
2023Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping NATURE COMMUNICATIONS
2024Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosis GENOME MEDICINE
2023Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients with pancreatic cancer: a prospective study FRONTIERS IN ONCOLOGY
2015Predominant Activation of JAK/STAT3 Pathway by Interleukin-6 Is Implicated in Hepatocarcinogenesis NEOPLASIA
2024Randomized Trial of Prophylactic Antibiotics for Endoscopic Retrograde Cholangiopancreatography in Patients With Biliary Obstruction AMERICAN JOURNAL OF GASTROENTEROLOGY
2022Safety and Efficacy of Allogeneic Natural Killer Cells in Combination with Pembrolizumab in Patients with Chemotherapy-Refractory Biliary Tract Cancer: A Multicenter Open-Label Phase 1/2a Trial CANCERS
2022Tumour-infiltrating bystander CD8+ T cells activated by IL-15 contribute to tumour control in non-small cell lung cancerLUNG CANCER
1

Browse

Links